ABSTRACT
In order to investigate the modulatory effect of purple sweet potato anthocyanins (PSPAs) on human intestinal microbiota, PSPAs were prepared by column chromatography and their influence on intestinal microbiota was analyzed by monitoring the bacterial populations and analyzing short-chain fatty acid (SCFA) concentrations at different time points. The numbers (log10 cell/mL) of Bifidobacterium and Lactobacillus/Enterococcus spp., Bacteroides-Prevotella, Clostridium histolyticum, and total bacteria after 24 h of culture in anaerobic fermentation broth containing PSPAs were 8.44 ± 0.02, 8.30 ± 0.01, 7.80 ± 0.03, 7.60 ± 0.03, and 9.00 ± 0.02, respectively, compared with 8.21 ± 0.03, 8.12 ± 0.02, 7.95 ± 0.02, 7.77 ± 0.02, and 9.01 ± 0.03, respectively, in the controls. The results showed that PSPAs induced the proliferation of Bifidobacterium and Lactobacillus/Enterococcus spp., inhibited the growth of Bacteroides-Prevotella and Clostridium histolyticum, and did not affect the total bacteria number. Total SCFA concentrations in the cultures with PSPAs were significantly higher than in the controls (P < 0.05). Moreover, during the fermentation, the PSPAs were partially fragmented to phenolic acids, which may exert a better effect on intestinal microecology, suggesting that PSPAs may have prebiotic-like activity by generating SCFAs and modulating the intestinal microbiota, contributing to improvements in human health.
Subject(s)
Anthocyanins/analysis , Gastrointestinal Microbiome/drug effects , Ipomoea batatas/chemistry , Anthocyanins/pharmacology , Bacteroides/drug effects , Bacteroides/growth & development , Bifidobacterium/growth & development , Clostridium histolyticum/drug effects , Clostridium histolyticum/growth & development , Fatty Acids, Volatile/analysis , Fermentation , Humans , Intestines/microbiology , Lactobacillus/growth & development , Prebiotics/analysisABSTRACT
With the aim of investigating the potential of flavan-3-ols to influence the growth of intestinal bacterial groups, we have carried out the in vitro fermentation, with human faecal microbiota, of two purified fractions from grape seed extract (GSE): GSE-M (70% monomers and 28% procyanidins) and GSE-O (21% monomers and 78% procyanidins). Samples were collected at 0, 5, 10, 24, 30 and 48 h of fermentation for bacterial enumeration by fluorescent in situ hybridization and for analysis of phenolic metabolites. Both GSE-M and GSE-O fractions promoted growth of Lactobacillus/Enterococcus and decrease in the Clostridium histolyticum group during fermentation, although the effects were only statistically significant with GSE-M for Lactobacillus/Enterococcus (at 5 and 10 h of fermentation) and GSE-O for C. histolyticum (at 10 h of fermentation). Main changes in polyphenol catabolism also occurred during the first 10 h of fermentation; however, no significant correlation coefficients (P > 0.05) were found between changes in microbial populations and precursor flavan-3-ols or microbial metabolites. Together, these data suggest that the flavan-3-ol profile of a particular food source could affect the microbiota composition and its catabolic activity, inducing changes that could in turn affect the bioavailability and potential bioactivity of these compounds.
Subject(s)
Feces/microbiology , Fermentation , Flavonoids/metabolism , Vitis/chemistry , Clostridium histolyticum/growth & development , Clostridium histolyticum/metabolism , Enterococcus/growth & development , Enterococcus/metabolism , Grape Seed Extract/metabolism , Humans , Lactobacillus/growth & development , Lactobacillus/metabolism , Metagenome , Polyphenols/metabolism , Proanthocyanidins/metabolism , Seeds/metabolismABSTRACT
AIMS: The aim of this study was to evaluate the impact of the administration of microencapsulated Lactobacillus plantarum CRL 1815 with two combinations of microbially derived polysaccharides, xanthan : gellan gum (1%:0·75%) and jamilan : gellan gum (1%:1%), on the rat faecal microbiota. METHODS AND RESULTS: A 10-day feeding study was performed for each polymer combination in groups of 16 rats fed either with placebo capsules, free or encapsulated Lact. plantarum or water. The composition of the faecal microbiota was analysed by fluorescence in situ hybridization and temporal temperature gradient gel electrophoresis. Degradation of placebo capsules was detected, with increased levels of polysaccharide-degrading bacteria. Xanthan : gellan gum capsules were shown to reduce the Bifidobacterium population and increase the Clostridium histolyticum group levels, but not jamilan : gellan gum capsules. Only after administration of jamilan : gellan gum-probiotic capsules was detected a significant increase in Lactobacillus-Enterococcus group levels compared to controls (capsules and probiotic) as well as two bands were identified as Lact. plantarum in two profiles of ileum samples. CONCLUSIONS: Exopolysaccharides constitute an interesting approach for colon-targeted delivery of probiotics, where jamilan : gellan gum capsules present better biocompatibility and promising results as a probiotic carrier. SIGNIFICANCE AND IMPACT OF STUDY: This study introduces and highlights the importance of biological compatibility in the encapsulating material election, as they can modulate the gut microbiota by themselves, and the use of bacterial exopolysaccharides as a powerful source of new targeted-delivery coating material.
Subject(s)
Drug Carriers/chemistry , Feces/microbiology , Lactobacillus plantarum , Metagenome , Probiotics/administration & dosage , Animals , Bifidobacterium/genetics , Bifidobacterium/growth & development , Biodiversity , Capsules , Clostridium histolyticum/genetics , Clostridium histolyticum/growth & development , Electrophoresis, Gel, Pulsed-Field , Female , Gastrointestinal Tract/microbiology , Polymers/chemistry , Polysaccharides, Bacterial/chemistry , RNA, Ribosomal, 16S/genetics , Rats , Rats, WistarSubject(s)
Creutzfeldt-Jakob Syndrome/etiology , Islets of Langerhans Transplantation/adverse effects , Animals , Cattle , Cell Separation/methods , Clostridium histolyticum/enzymology , Clostridium histolyticum/growth & development , Creutzfeldt-Jakob Syndrome/transmission , Culture Media/adverse effects , Encephalopathy, Bovine Spongiform/etiology , Encephalopathy, Bovine Spongiform/transmission , Humans , Microbial Collagenase/isolation & purification , Models, Statistical , Monte Carlo Method , Risk Assessment/statistics & numerical dataABSTRACT
Stirred, pH-controlled anaerobic batch cultures were used to investigate the in vitro effects of galacto-oligosaccharides (GOS) alone or combined with the probiotic Bifidobacterium bifidum 02 450B on the canine faecal microbiota of three different donors. GOS supported the growth of B. bifidum 02 450B throughout the fermentation. Quantitative analysis of bacterial populations by FISH revealed significant increases in Bifidobacterium spp. counts (Bif164) and a concomitant decrease in Clostridium histolyticum counts (Chis150) in the synbiotic-containing vessels compared with the controls and GOS vessels. Vessels containing probiotic alone displayed a transient increase in Bifidobacterium spp. and a transient decrease in Bacteroides spp. Denaturing gradient gel electrophoresis analysis showed that GOS elicited similar alterations in the microbial profiles of the three in vitro runs. However, the synbiotic did not alter the microbial diversity of the three runs to the same extent as GOS alone. Nested PCR using universal primers, followed by bifidobacterial-specific primers illustrated low bifidobacterial diversity in dogs, which did not change drastically during the in vitro fermentation. This study illustrates that the canine faecal microbiota can be modulated in vitro by GOS supplementation and that GOS can sustain the growth of B. bifidum 02 450B in a synbiotic combination.
Subject(s)
Bifidobacterium/growth & development , Feces/microbiology , Fermentation , Metagenome , Probiotics , Animals , Bifidobacterium/genetics , Bifidobacterium/metabolism , Clostridium histolyticum/growth & development , Colony Count, Microbial , Culture Media , DNA, Bacterial/genetics , Dogs , Oligosaccharides/metabolismSubject(s)
Autistic Disorder/microbiology , Clostridium histolyticum/isolation & purification , Gastrointestinal Tract/microbiology , Adolescent , Child , Child, Preschool , Clostridium histolyticum/growth & development , Clostridium histolyticum/pathogenicity , Feces/microbiology , Female , Humans , In Situ Hybridization, Fluorescence , Male , Sex FactorsABSTRACT
Prebiotics are nondigestible food ingredients that encourage proliferation of selected groups of the colonic microflora, thereby altering the composition toward a more beneficial community. In the present study, the prebiotic potential of a novel galactooligosaccharide (GOS) mixture, produced by the activity of galactosyltransferases from Bifidobacterium bifidum 41171 on lactose, was assessed in vitro and in a parallel continuous randomized pig trial. In situ fluorescent hybridization with 16S rRNA-targeted probes was used to investigate changes in total bacteria, bifidobacteria, lactobacilli, bacteroides, and Clostridium histolyticum group in response to supplementing the novel GOS mixture. In a 3-stage continuous culture system, the bifidobacterial numbers for the first 2 vessels, which represented the proximal and traverse colon, increased (P < 0.05) after the addition of the oligosaccharide mixture. In addition, the oligosaccharide mixture strongly inhibited the attachment of enterohepatic Escherichia coli (P < 0.01) and Salmonella enterica serotype Typhimurium (P < 0.01) to HT29 cells. Addition of the novel mixture at 4% (wt:wt) to a commercial diet increased the density of bifidobacteria (P < 0.001) and the acetate concentration (P < 0.001), and decreased the pH (P < 0.001) compared with the control diet and the control diet supplemented with inulin, suggesting a great prebiotic potential for the novel oligosaccharide mixture.